Ask Warren

D&D Pharmatech

347850 · KOSDAQ · ₩347850 · 디앤디파마텍

₩40,850▼ ₩850 (2.04%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩662M₩129M₩990M₩969M₩925M₩1.4B₩5.1B₩1.9B
Operating income−₩9.9B−₩11B−₩10B−₩6.2B−₩8.1B−₩9.3B−₩6.9B−₩7B
Net income−₩7.8B−₩10B₩1.9B−₩5.8B−₩10B−₩10B−₩9.8B−₩8.1B
Net income to shareholders−₩8.3B−₩9.5B₩1.8B−₩5.6B−₩9.9B−₩9.8B−₩9.4B−₩8B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩320B₩92B₩98B₩93B₩98B₩89B₩97B₩102B
Current assets₩185B₩46B₩51B₩45B₩49B₩33B₩40B₩44B
Cash and equivalents₩12B₩25B₩33B₩38B₩40B₩26B₩30B₩38B
Total liabilities₩186B₩19B₩19B₩18B₩20B₩25B₩28B₩27B
Current liabilities₩6.8B₩5.7B₩5.4B₩4.6B₩5.6B₩9.3B₩11B₩11B
Borrowings₩110B₩0₩0₩0₩0₩917M₩1.8B₩1.7B
Total equity₩134B₩74B₩79B₩75B₩78B₩63B₩70B₩75B
Shareholders' equity₩135B₩75B₩79B₩75B₩79B₩64B₩70B₩66B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩7.3B−₩9.7B−₩5.2B−₩2.7B−₩7.3B−₩5.9B−₩8.3B−₩5B
Capital spending−₩4.2M₩0−₩7M−₩30M₩473,363−₩28M−₩141M−₩213M
Free cash flow−₩7.3B−₩9.7B−₩5.2B−₩2.8B−₩7.3B−₩5.9B−₩8.4B−₩5.3B

Consolidated where available. Amounts in won.

Also known as: D&D Pharmatech / 디앤디파마텍 / 347850 / KRX:347850

Source: KRX statistical information